Cervical cancer, version 2.2015.

This article outlines relevant data and provides insight into panel decisions regarding various combination regimens. Additionally, a new section was added to provide additional guidance on key principles of evaluation and surgical staging in cervical cancer. This article highlights 2 areas of active investigation and debate from this new section: sentinel lymph node mapping and fertility-sparing treatment approaches. PMID: 25870376 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research

Related Links:

Publication date: September–October 2019Source: Journal of the American Society of Cytopathology, Volume 8, Issue 5Author(s): Caddie Laberiano, Wilmer Silva Caso
Source: Journal of the American Society of Cytopathology - Category: Cytology Source Type: research
Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Uterine Cervical Neoplasms;   Cervical Cancer;   Cervical Neoplasms;   Cervix Cancer Interventions:   Drug: Sintilimab;   Drug: quadrivalent HPV vaccine Sponsors:   Buhai Wang;   Innovent Biologics (Suzhou) Co. Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Cervical Cancer, Endometrial Cancer,Endometrial Lesion&Adnexal Lesion ,Ectopic Pregnancy&Infertility ,Pelvic Obstructive Disorder&Genital Tract Deformity Intervention:   Sponsors:   Peking Union Medical College Hospital;   Chinese Medical Doctor Association;   Chinese Obstetricians and Gynecologists Association Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
[allAfrica] Johannesburg -The government of Senegal will begin to offer free breast or cervical cancer chemotherapy in public hospitals from October 2019, reports the BBC.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
CDC estimates that 92% of cancers caused by HPV could be eliminated in the US if HPV vaccination recommendations in this country are followed Medical laboratories in the United States once processed as many as 55-million Pap tests each year. However, the need for cervical cancer screening tests is diminishing. That’s primarily because the human […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology anatomic pathology Brett Giroir MD CDC centers for disease control and Source Type: news
Patients with non-Hodgkin's lymphoma who received radiation 30 days or less...Read more on AuntMinnie.comRelated Reading: ASTRO: AI predicts side effects from radiation therapy ASTRO: Is hormone therapy after prostate surgery needed? ASTRO: SABR generates immune response to prostate cancer ASTRO: Cervical cancer deaths rise as women's centers close ASTRO: Whole, partial breast RT yield similar cosmetic results
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Avastin | Cancer | Cancer & Oncology | Cervical Cancer | Reproduction Medicine